Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Berghmans

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
The European Respiratory Journal|October 2, 2012
Euthanasia: from ethical debate to clinical realityThierry Berghmans, Dominique Lossignol
Translational Lung Cancer Research|August 25, 2021
Oligometastatic non-small cell lung cancer: from biology to clinical practiceMaurizio V Infante, Thierry Berghmans
Frontiers in Medicine|December 13, 2021
Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted TherapiesThierry Berghmans, Jacques Cadranel, Bogdan Grigoriu
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Anaplastic lymphoma kinase (<i>ALK</i>) inhibitors for second-line therapy of non-small cell lung cancerThierry Berghmans, Myriam Remmelink, Ahmad Awada
Translational Lung Cancer Research|August 25, 2021
Current and future research efforts in oligometastatic non-small cell lung cancer-a systematic reviewMariana Brandão, Valérie Durieux, Thierry Berghmans
Therapeutic Advances in Medical Oncology|September 10, 2011
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variablesThierry Berghmans, Marianne Paesmans, Jean-Paul Sculier
Lung Cancer (Amsterdam, Netherlands)|November 23, 2006
Second-line treatment for advanced non-small cell lung cancer: how to design a clinical trial for a new agent?Marianne Paesmans, Thierry Berghmans, Jean-Paul Sculier
The European Respiratory Journal|February 21, 2015
Management of EGFR mutated nonsmall cell lung carcinoma patientsBogdan Grigoriu, Thierry Berghmans, Anne-Pascale Meert
Chest|July 11, 2003
A prospective study of infections in lung cancer patients admitted to the hospitalThierry Berghmans, Jean-Paul Sculier, Jean Klastersky
The European Respiratory Journal|July 2, 2015
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutationsThierry Berghmans, Anne-Pascale Meert, Elisabeth Quoix
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
The European Respiratory Journal|October 2, 2012
Euthanasia: from ethical debate to clinical realityThierry Berghmans, Dominique Lossignol
Translational Lung Cancer Research|August 25, 2021
Oligometastatic non-small cell lung cancer: from biology to clinical practiceMaurizio V Infante, Thierry Berghmans
Frontiers in Medicine|December 13, 2021
Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted TherapiesThierry Berghmans, Jacques Cadranel, Bogdan Grigoriu
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Anaplastic lymphoma kinase (<i>ALK</i>) inhibitors for second-line therapy of non-small cell lung cancerThierry Berghmans, Myriam Remmelink, Ahmad Awada
Translational Lung Cancer Research|August 25, 2021
Current and future research efforts in oligometastatic non-small cell lung cancer-a systematic reviewMariana Brandão, Valérie Durieux, Thierry Berghmans
Therapeutic Advances in Medical Oncology|September 10, 2011
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variablesThierry Berghmans, Marianne Paesmans, Jean-Paul Sculier
Lung Cancer (Amsterdam, Netherlands)|November 23, 2006
Second-line treatment for advanced non-small cell lung cancer: how to design a clinical trial for a new agent?Marianne Paesmans, Thierry Berghmans, Jean-Paul Sculier
The European Respiratory Journal|February 21, 2015
Management of EGFR mutated nonsmall cell lung carcinoma patientsBogdan Grigoriu, Thierry Berghmans, Anne-Pascale Meert
Chest|July 11, 2003
A prospective study of infections in lung cancer patients admitted to the hospitalThierry Berghmans, Jean-Paul Sculier, Jean Klastersky
The European Respiratory Journal|July 2, 2015
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutationsThierry Berghmans, Anne-Pascale Meert, Elisabeth Quoix
Pageof 10